https://www.selleckchem.com/pr....oducts/anacetrapib-m
Sweden revised their cervical cancer screening program in 2017 to include cytology-based screening for women aged 23-29 years and primary human papillomavirus (HPV) testing for women aged 30-64 years; however, alternative strategies may be preferred. To inform cervical cancer prevention policies for unvaccinated women, we evaluated the cost-effectiveness of alternative screening strategies, including the current Swedish guidelines. We adapted a mathematical simulation model of HPV and cervical cancer to the Swedish context u
Like
Comment
Share
